ArticleCancer science2020

Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.

Tatsuki Ueda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.